FDA Inspection
Procter & Gamble Manufactura S. de R.L. de C.V.Procter & Gamble Manufactura S. de R.L. de C.V. – FDA Inspection, Jun 15, 2018
Record Details
This FDA Inspection record concerns Procter & Gamble Manufactura S. de R.L. de C.V., with an inspection on June 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 60faf994-2434-4872-b75b-6bb4701ba429
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055804
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Procter & Gamble Manufactura S. de R.L. de C.V.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| March 6, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Procter & Gamble Manufactura S. de R.L. de C.V.
- FDA Inspection 1275297 - 2025-06-27
- FDA Inspection 922870 - 2015-03-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.